Pyrazolooxazines, pyrazolothiazines, and pryazoloquinolines and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514225, 514227, 514228, 514229, 514231, 514232, 514233, 514234, 514236, 514237, 514239, 514293, 544 14, 544 34, 544 74, 544 99, 544101, 546 64, 546 65, 546 82, 546 83, A61K 31535, A61K 3154, C07D49804, C07D51304

Patent

active

045528748

ABSTRACT:
The invention relates to pyrazolooxazines, pyrazolothiazines and pyrazoloquinolines defined herein by Formula I. The invention also includes compositions containing said Formula I compounds and methods for the use of said compounds and compositions for their lipoxygenase-inhibiting properties. Also included in the invention are methods for the manufacture of said compounds of Formula I.

REFERENCES:
Mazharuddin et al., Tet. Letters, No. 4 (1971), pp. 307-310.
Aki et al., Chemical Abstracts, vol. 77 (1972), 139934r.
Maki et al., Chemical Abstracts, vol 78 (1973), 136199q.
Maki et al., Chemical Abstracts, vol. 81 (1974), 3953w.
Okafor et al., Chemical Abstracts, vol. 88 (1978), 190619w.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolooxazines, pyrazolothiazines, and pryazoloquinolines and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolooxazines, pyrazolothiazines, and pryazoloquinolines and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolooxazines, pyrazolothiazines, and pryazoloquinolines and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1880333

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.